Key Quantitative Details

  • Number of shares allotted: 8,900 fully paid-up equity shares
  • Face value: Re. 1 per share
  • Exercise price per share: ₹188.90
  • Premium per share: ₹187.90
  • Total proceeds from exercise: ₹16,81,210
  • Date of allotment: 10 July 2026
  • Distinctive numbers: 21,22,86,017 to 21,22,94,916 (both inclusive)

Capital Structure Impact

  • Total issued shares after allotment: 21,22,94,916 equity shares
  • Total issued share capital after allotment: 21,22,94,916 (representing the number of shares, with face value Re. 1 each)

Regulatory Compliance Details

  • SEBI Regulation: Disclosure made under Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015
  • Additional compliance: Includes details as per Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 and SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024
  • Previous filing: Statement under regulation 10(b) was filed with both BSE and NSE on 08 January 2025 (BSE Filing No.: 220872, NSE Filing No.: 46558)

Scheme Details

  • ESOP Plan: Employees Stock Option Plan 2008
  • Objective: To provide incentive to attract, retain and reward employees and contribute to company growth
  • Maximum vesting period: 5 years with multiple vesting options
  • Exercise period: Until employee remains in company service
  • Shares issued in: Dematerialized form
  • Lock-in details: Not applicable